Pheno Therapeutics

Pheno Therapeutics is an early-stage biotechnology company with a highly differentiated small-molecule drug discovery platform, aimed at delivering a new class of transformative regenerative and neuroprotective therapies. Our mission is to discover, develop, and deliver first-in-class oligodendrocyte-based neuroprotective treatments for multiple sclerosis and other serious neurological conditions with significant unmet medical needs.